SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $2,532,000 | -30.0% | 226,098 | -31.2% | 0.01% | -33.3% |
Q2 2017 | $3,617,000 | +42.1% | 328,788 | +26.5% | 0.02% | +36.4% |
Q1 2017 | $2,546,000 | +24.5% | 259,822 | +37.2% | 0.01% | +22.2% |
Q4 2016 | $2,045,000 | -30.2% | 189,320 | -33.8% | 0.01% | -35.7% |
Q3 2016 | $2,930,000 | +49.0% | 285,833 | +89.9% | 0.01% | +40.0% |
Q2 2016 | $1,966,000 | +9.5% | 150,511 | -7.7% | 0.01% | +11.1% |
Q1 2016 | $1,795,000 | +23.7% | 163,149 | +3.5% | 0.01% | +28.6% |
Q4 2015 | $1,451,000 | +70.9% | 157,681 | +28.8% | 0.01% | +75.0% |
Q3 2015 | $849,000 | -8.1% | 122,390 | +30.1% | 0.00% | -20.0% |
Q2 2015 | $924,000 | +616.3% | 94,076 | +544.2% | 0.01% | +400.0% |
Q1 2015 | $129,000 | +0.8% | 14,603 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $128,000 | -36.3% | 14,603 | -50.0% | 0.00% | 0.0% |
Q3 2014 | $201,000 | +30.5% | 29,205 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $154,000 | +15.8% | 29,205 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $133,000 | -9.5% | 29,205 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $147,000 | – | 29,205 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |